Núria Viñolas

Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial

Mariano Provencio, Ernest Nadal, Amelia Insa et al. · The Lancet Oncology · 2020 · 788 citations

Medicine, Immune Checkpoint Inhibitor, Cancer Treatment +4

Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma

Aleix Prat, Alejandro Navarro, Laia Paré et al. · Cancer Research · 2017 · 468 citations

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

Manuel Cobo, Dolores Isla, Bartomeu Massutí et al. · Journal of Clinical Oncology · 2007 · 442 citations · Full text

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

Francesc Graus, J Dalmou, R. Reñé et al. · Journal of Clinical Oncology · 1997 · 373 citations

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer

Elena Gallardo, Alfons Navarro, Núria Viñolas et al. · Carcinogenesis · 2009 · 342 citations · Full text